DETRALEX 500mg film-coated tablets SERVIER
diosmin Indicated for: chronic venous insufficiency; capillary fragility
C05CA53 Cardiovascular system | Capillary stabilizing agents | Bioflavonoids
letter D · page 21
diosmin Indicated for: chronic venous insufficiency; capillary fragility
C05CA53 Cardiovascular system | Capillary stabilizing agents | Bioflavonoids
tolterodine Indicated for: overactive bladder; urinary incontinence
tolterodine Indicated for: overactive bladder; urinary incontinence
benzalkonium chloride Indicated for: local antisepsis
troxerutine Indicated for: chronic venous insufficiency; capillary fragility
C05CA04 Cardiovascular system | Capillary stabilizing agents | Bioflavonoids
diosmin Indicated for: chronic venous insufficiency; capillary fragility
C05CA53 Cardiovascular system | Capillary stabilizing agents | Bioflavonoids
diosmin Indicated for: chronic venous insufficiency; capillary fragility
C05CA53 Cardiovascular system | Capillary stabilizing agents | Bioflavonoids
dexamethasone Indicated for: inflammation; cancer; COVID-19
S01BA01 Sensory organs | Antiinflammatory agents | Corticosteroids, plain
dexamethasone + neomycin Indicated for: bacterial infections
dexamethasone Indicated for: inflammation; cancer; COVID-19
dexamethasone Indicated for: inflammation; cancer; COVID-19
dexamethasone Indicated for: inflammation; cancer; COVID-19
dexamethasone Indicated for: inflammation; cancer; COVID-19
S01BA01 Sensory organs | Antiinflammatory agents | Corticosteroids, plain
dexamethasone Indicated for: inflammation; cancer; COVID-19
dexamethasone Indicated for: inflammation; cancer; COVID-19
dexamethasone Indicated for: inflammation; cancer; COVID-19
dexamethasone Indicated for: inflammation; cancer; COVID-19
dexamethasone Indicated for: inflammation; cancer; COVID-19
dexamethasone Indicated for: inflammation; cancer; COVID-19
dexamethasone Indicated for: inflammation; cancer; COVID-19